Citi analyst Peter Verdult lowered the firm’s price target on Evotec to EUR 21 from EUR 28 and keeps a Neutral rating on the shares.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on EVO:
- Evotec price target lowered to EUR 26 from EUR 30 at Deutsche Bank
- Evotec, TIAP expand LAB150 BRIDGE partnership to include Amgen
- Evotec, TIAP expand LAB150 BRIDGE partnership to expand Amgen
- Evotec enters strategic collaboration with Adapsyn Bioscience
- Evotec initiates ground-breaking for new biologics facility
